Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DK8BS7
|
|||
| Drug Name |
BAY1097761
|
|||
| Synonyms |
Adrenomedullin Pegol; PEG-ADM
Click to Show/Hide
|
|||
| Indication | Acute respiratory distress syndrome [ICD-11: CB00; ICD-10: J80] | Phase 2 | [1] | |
| Respiratory distress syndrome [ICD-11: CB00; ICD-10: J80; ICD-9: 518.5, 518.82] | Phase 2 | [1] | ||
| Company |
Bayer
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Adrenomedullin (ADM) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04417036) Safety and Efficacy of Inhaled Pegylated Adrenomedullin (PEG-ADM) in Patients Suffering From Acute Respiratory Distress Syndrome (ARDS): a Double-blind, Randomized, Placebo-controlled, Multicenter Phase 2a/b Clinical Trial. U.S.National Institutes of Health. | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.